ACTIVE

Boehringer Ingelheim Animal Health Belgium SA

Financial year 2025 · Closed on 31/12/2025

Net result234 k €-83,0 %over 1 year
Revenue50,6 M €+8,0 %over 1 year
Equity4,2 M €0,0 %over 1 year
Workforce38,4 ETP-0,8 %over 1 year

Identity

Source · BCE/KBO

Boehringer Ingelheim Animal Health Belgium SA is a Public limited company incorporated in 1991. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Ixelles. It employs on average 38,4 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0445.411.231
Incorporation
08/10/1991
Legal form
Public limited company
Registered office
Avenue Arnaud Fraiteur 15/23
1050 Ixelles · BruxellesSee on map
Contributed capital
3 490 182,99 €
Latest accounts
31/12/2025
Average workforce
38,4 ETP
Joint committees (2)
  • 200
  • 218
Signals
ProfitableGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 21 filings

Trend over 20 financial years

20252024202320222021
Income statement
Revenue50,6 M €46,9 M €41 M €36,2 M €35,2 M €
EBITDA1,8 M €2,6 M €1,9 M €2,1 M €873,8 k €
Operating result723,2 k €2,2 M €1,4 M €1,7 M €884,3 k €
Net result234 k €1,4 M €787,9 k €1 M €408,5 k €
Balance sheet
Equity4,2 M €4,2 M €4,2 M €4,2 M €5,2 M €
Total assets24 M €21,9 M €18,1 M €17,3 M €17,6 M €
Cash–––––
Debts18,8 M €16,6 M €12,9 M €12,2 M €11,5 M €
Other
Workforce38,4 ETP38,7 ETP38,1 ETP36,6 ETP33,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

9 active · 33 ended

Active mandates

DirectorFunctionMandateOther mandatescurrentendedstruck offbankruptcies
Stephan KRICK
Managing director01/06/2026 → 31/05/2029
Lukas HAUSCHILD
Director01/05/2026 → 30/04/2029
000
Carla RAMON
Director09/03/2026 → 08/03/2029
000
Christoph TAUTPHAEUS
Director01/11/2025 → 01/05/2026
Larisa NURKANOVIC
Director01/11/2025 → 09/03/2026
Carla RAMON
Director01/04/2025 → 01/11/2025
000
Sebastian GUIJARRO
Director06/04/2024 → 30/11/2025
000
Chiedza KAITANO
Director15/03/2024 → 03/03/2025
Luis Miguel VITORIA MAGRO CORREIA
Managing director15/06/2023 → 01/10/2025

Ended mandates

DirectorFunctionMandateOther mandatescurrentendedstruck offbankruptcies
Sebastian GUIJARRO
Director06/04/2024 → 11/06/2031
000
Chiedza KAITANO
Director15/03/2024 → 11/06/2031
Eva PORTA SOLDEVILA
Director09/10/2023 → 06/04/2024
Luis Miguel VITORIA MAGRO CORREIA
Managing director15/06/2023 → 14/06/2028

Other companies at this address

Avenue Arnaud Fraiteur 15/23 1050 Ixelles
CompanyCBE no.
0457.572.754
ALIAXIS● Active
0860.005.067
ANK4PAT● Active
0704.672.138
ARTSNBE● Active
0678.993.169
BeeOdiversity● Active
0848.557.582
0448.020.729
0435.953.632
CODINSANITY● Active
0699.660.802
0792.385.179
DYNA Specialist● Active
0779.400.047
ENTITY FACTORY● Active
1003.909.418
ERATHIS● Active
0783.780.388
EVOLUNO● Active
0758.358.272
FESTRA● Active
0648.886.646
GLUCÔNE● Active
0878.220.776
GUZMANZI● Active
0782.965.885
Health INN-PACT● Active
0726.794.571
JH PARTNERS● Active
1022.465.023
Krys Construct● Active
0534.791.781
Laboratoires Titra● Bankrupt
0402.249.102

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date29/06/202626/06/202526/06/202420/06/202322/06/202221/06/2021
General meeting26/06/202625/06/202512/06/202414/06/202308/06/202209/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202526/06/202629/06/2026FrenchPDF
Full model31/12/202425/06/202526/06/2025FrenchPDF
Full model31/12/202312/06/202426/06/2024FrenchPDF
Full model31/12/202214/06/202320/06/2023FrenchPDF
Full model31/12/202108/06/202222/06/2022FrenchPDF
Full model31/12/202009/06/202121/06/2021FrenchPDF
Full model31/12/201910/06/202016/06/2020FrenchPDF
Full model31/12/201812/06/201927/06/2019FrenchPDF
Full model31/12/201713/06/201826/06/2018FrenchPDF
Full model31/12/201614/06/201729/06/2017DutchPDF
Full model31/12/201508/06/201608/07/2016DutchPDF
Full model31/12/201410/06/201524/06/2015DutchPDF
Full model31/12/201311/06/201401/07/2014DutchPDF
Full model31/12/201212/06/201328/06/2013DutchPDF
Full model31/12/201113/06/201203/08/2012DutchPDF
Full model31/12/201008/06/201127/06/2011FrenchPDF
Full model31/12/200909/06/201028/06/2010FrenchPDF
Full model31/12/200810/06/200929/06/2009FrenchPDF
Full model31/12/200711/06/200804/07/2008FrenchPDF
Full modelCorrection31/12/200613/06/200712/09/2007FrenchPDF
Full model31/12/200613/06/200709/07/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

9 active · 33 ended

Active mandates

DirectorFunctionMandateOther mandatescurrentendedstruck offbankruptcies
Stephan KRICK
Managing director01/06/2026 → 31/05/2029
Lukas HAUSCHILD
Director01/05/2026 → 30/04/2029
000
Carla RAMON
Director09/03/2026 → 08/03/2029
000
Christoph TAUTPHAEUS
Director01/11/2025 → 01/05/2026
Larisa NURKANOVIC
Director01/11/2025 → 09/03/2026
Carla RAMON
Director01/04/2025 → 01/11/2025
000
Sebastian GUIJARRO
Director06/04/2024 → 30/11/2025
000
Chiedza KAITANO
Director15/03/2024 → 03/03/2025
Luis Miguel VITORIA MAGRO CORREIA
Managing director15/06/2023 → 01/10/2025

Ended mandates

DirectorFunctionMandateOther mandatescurrentendedstruck offbankruptcies
Sebastian GUIJARRO
Director06/04/2024 → 11/06/2031
000
Chiedza KAITANO
Director15/03/2024 → 11/06/2031
Eva PORTA SOLDEVILA
Director09/10/2023 → 06/04/2024
Luis Miguel VITORIA MAGRO CORREIA
Managing director15/06/2023 → 14/06/2028

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates22/05/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Other16/04/2026
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates23/02/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates27/05/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates09/10/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates13/08/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates22/05/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates10/11/2023
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025234 k €↓
  2. 2024
    Annual accounts 20241,4 M €↑
  3. 2023
    Annual accounts 2023787,9 k €↓
  4. 2022
    Annual accounts 20221 M €↑
  5. 2021
    Annual accounts 2021408,5 k €↓
  6. 2020
    Annual accounts 2020965,4 k €↑
  7. 2019
    Annual accounts 2019639,9 k €↑
  8. 2018
    Annual accounts 201890,7 k €↑
  9. 2017
    Annual accounts 2017-207,4 k €↓
  10. 2017
    Name changeBoehringer Ingelheim Animal Health Belgium SA
  11. 2016
    Annual accounts 2016477,4 k €↓
  12. 2015
    Annual accounts 2015572,6 k €↑
  13. 2014
    Annual accounts 2014563,8 k €↓
  14. 2013
    Annual accounts 2013686,5 k €↑
  15. 2012
    Annual accounts 2012354,1 k €↓
  16. 2011
    Annual accounts 2011450 k €↓
  17. 2010
    Annual accounts 2010666,4 k €↓
  18. 2009
    Annual accounts 20091,3 M €↑
  19. 2008
    Annual accounts 20081,2 M €↑
  20. 2007
    Annual accounts 20071,1 M €↑
  21. 2006
    Annual accounts 2006806,9 k €
  22. 08/10/1991
    IncorporationPublic limited company

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Boehringer Ingelheim Animal Health Belgium SACurrent
accounts 2017 → 2025 · CBE, tracked since 27/09/2026
Accounts 2025 · 2026-00238250
MERIAL BELGIUM
accounts 2006 → 2016
Accounts 2016 · 2017-24700490

Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.